HIT Consultant January 14, 2026
For decades, drug safety has depended on one simple but demanding task: turning fragments of information from patients, physicians, and trials into clear signals that protect lives. Today, that responsibility sits at the center of a digital revolution. Artificial intelligence and automation are transforming pharmacovigilance from a manual, reactive discipline into one that is fast, predictive, and globally connected. The change is cultural, reshaping how safety professionals think, collaborate, and ensure trust in the medicines we all rely on.
Prior to technology-enabled process transformation, key activities of pharmacovigilance like data intake, evaluation, follow-up, and distribution were not only manually & resource-intensive but also dealt with a greater risk of missing out key information needed to ensure patient safety from a...
Today's Sponsors
Today's Sponsor